Medically reviewed by Dr. Tom Biernacki, DPM
Board-certified podiatric surgeon | Balance Foot & Ankle, Howell & Bloomfield Hills, MI
Last reviewed: May 2026
The most important clinical decision with Nail Fungus Treatment: Fingernail vs Toenail Options Compared isn’t which treatment to choose — it’s identifying which subtype you have first. Our podiatrists see patients treated for the wrong subtype for months before the correct diagnosis leads to full resolution. Call (810) 206-1402 — expert podiatric care across Michigan.

| Treatment | Cure Rate (Toenail) | Cure Rate (Fingernail) | Duration | Key Advantage |
|---|---|---|---|---|
| Oral terbinafine (Lamisil) | 38–76% | 59–86% (faster nail growth) | 6 wks (fingernail) / 12 wks (toenail) | Highest cure rate; fungicidal; persists 12 months |
| Oral itraconazole (Sporanox) | 35–70% | Similar | 12 weeks pulse | Covers Candida; useful for fingernail Candida cases |
| Efinaconazole 10% (Jublia) | 17.8% | Not studied in fingernails | 48 weeks | Highest topical cure rate; no systemic risk |
| Ciclopirox lacquer (Penlac) | 5.5–8.5% | Slightly higher (faster nail growth) | 48 weeks | No systemic drug interactions |
| Tea tree oil 100% | 11–18% | Anecdotal; no studies | 6–12 months | Best-evidenced home remedy; OTC |
| OTC clotrimazole / miconazole | Low (skin fungi only) | Better for Candida paronychia (cuticle) | 4–8 weeks | OTC; covers yeast; better around nail folds |
| Feature | Fingernail Fungus | Toenail Fungus |
|---|---|---|
| Most common cause | Dermatophytes + Candida (roughly equal) | Dermatophytes (>90% of cases) |
| Nail growth speed | ~3mm/month | ~1.5mm/month |
| Time to full clear nail | 6–9 months from treatment start | 12–18 months from treatment start |
| Oral terbinafine duration | 6 weeks | 12 weeks |
| Risk of Candida | Higher (especially in wet-work occupations) | Lower (primarily dermatophytes) |
| Prevalence | Less common | 10% of adults; up to 50% over age 70 |
| Associated conditions | Psoriasis; frequent water exposure; immune suppression | Athlete’s foot; diabetes; tight shoes; gym exposure |
Nail Fungus Treatment: Understanding Your Options
Nail fungus treatment differs significantly depending on whether the affected nail is a fingernail or toenail, which fungal species is responsible, and how much of the nail is involved. The core principle applies equally to both: antifungal medications need to either penetrate the nail plate to reach the infection or be absorbed systemically and delivered through the bloodstream to the nail bed. Here is how to choose the right treatment for your specific situation.
Fingernail vs. Toenail Fungus: Why the Treatment Differs
Fingernail fungus responds faster to treatment than toenail fungus for a straightforward biological reason: fingernails grow approximately twice as fast as toenails (3mm vs. 1.5mm per month). This means a full nail replacement — the endpoint of successful treatment — occurs in 6–9 months for fingernails vs. 12–18 months for toenails. Oral terbinafine dosing reflects this: 6 weeks for fingernails, 12 weeks for toenails, even though the therapeutic drug concentration achieved is the same.
Fingernail fungus also has a higher proportion of Candida cases (yeast rather than dermatophyte) compared to toenail fungus. This matters for drug selection: oral terbinafine is strongly fungicidal against dermatophytes but has limited activity against Candida. If a nail culture confirms Candida onychomycosis, itraconazole is the preferred oral agent. Identifying the causative species through a nail culture or PCR test before prescribing is particularly important when initial treatment has already failed.
Oral Antifungal Treatment: The Highest-Efficacy Option
For moderate-to-severe nail fungus involving more than 25% of the nail or affecting multiple nails, oral antifungal therapy provides the highest cure rates of any available treatment. Oral terbinafine achieves mycological cure (confirmed absence of fungus on culture or PCR) in 38–76% of toenail cases and 59–86% of fingernail cases. The drug achieves high concentrations in the nail plate within 2–4 weeks of starting treatment and remains detectable in nail tissue for up to 12 months after stopping, providing continued antifungal protection through the nail growth cycle.
Before starting oral terbinafine, baseline liver function tests (ALT, AST) are recommended. Serious hepatotoxicity is rare but is a recognized class risk. Terbinafine is a strong CYP2D6 inhibitor — it raises blood levels of certain antidepressants (TCAs, SSRIs metabolized by CYP2D6), antiarrhythmics (flecainide, propafenone), and beta-blockers (metoprolol). A thorough medication review before prescribing is required. Patients with a history of liver disease should generally be offered alternative treatments or closely monitored.
Topical Nail Fungus Treatments
Topical treatments are most appropriate for mild infection involving less than 25% of a single nail, or in patients who cannot take oral antifungals. The key limitation of all topicals is nail plate penetration: the human nail plate is a dense, keratin-rich structure 0.5–0.75mm thick, and most antifungal compounds do not reach therapeutic concentrations at the nail bed level.
Efinaconazole 10% solution (Jublia) is the best-evidenced topical nail antifungal, with two large Phase 3 trials and complete cure rates of 17.8% at 48 weeks of daily application. Its low viscosity allows better nail penetration than older lacquer formulations. Ciclopirox 8% lacquer (Penlac) achieves 5.5–8.5% complete cure in trials; it requires the most labor-intensive application protocol but is available as an affordable generic. OTC options like clotrimazole, miconazole, and topical terbinafine (Lamisil AT cream) have strong evidence for skin fungal infections (athlete’s foot, ringworm) but lack sufficient nail penetration for reliable onychomycosis treatment.
When Home Treatments Are Appropriate
Home remedies are reasonable first-line options only for very mild nail fungus: involvement of less than 25% of a single nail, no nail matrix involvement, and no patient risk factors (diabetes, immune suppression, peripheral vascular disease). Tea tree oil (100% pure, ISO 4730 grade) has the best clinical evidence among home remedies, with two randomized trials showing clinical improvement comparable to clotrimazole for mild cases. Applied twice daily for 6–12 months, it achieves mycological cure in approximately 11–18% of cases. Vicks VapoRub applied daily for 12 months achieved 27.8% mycological cure in a small RCT. Neither approaches the efficacy of oral terbinafine, but both are appropriate for patients with mild infection who prefer to attempt non-prescription therapy first.
Treating Nail Fungus: Why Diagnosis Matters Before Starting
Not all nail abnormalities are fungal. Nail psoriasis, trauma-related nail changes, lichen planus, and other conditions can produce yellowing, thickening, separation, and discoloration that closely mimics onychomycosis. Studies of patients empirically treated for presumed nail fungus show misdiagnosis rates of 20–50% — meaning a significant number of patients treated with antifungals for months do not actually have a fungal infection. Nail culture or PCR testing before treatment avoids this problem, confirms the fungal species, and is particularly important before starting a 12-week course of oral medication.
At Balance Foot & Ankle, Dr. Tom Biernacki and Dr. Carl Jay provide nail culture, diagnosis confirmation, and evidence-based nail fungus treatment at both the Howell and Bloomfield Hills offices. Call (810) 206-1402 for a nail evaluation.
American Academy of Dermatology: Nail Fungus
Ready to Get Relief?
Same-day appointments available in Howell & Bloomfield Hills, MI
4.9★ | 1,123 Reviews | 3,000+ Surgeries
Or call: (810) 206-1402
For a complete clinical overview: Toenail Fungus Complete Treatment Guide — oral, topical, laser and home remedy evidence reviewed
Dr. Tom Biernacki, DPM is a board-certified foot & ankle surgeon (ABFAS & ABPM) at Balance Foot & Ankle Specialists in Southeast Michigan. With over a decade of clinical experience, he specializes in heel pain, bunions, diabetic foot care, sports injuries, and minimally invasive surgery. Dr. Biernacki is a member of the APMA and ACFAS, and his patient education content on MichiganFootDoctors.com and YouTube has made him one of the most-followed foot & ankle educators on YouTube.